Cipla gains US FDA nod for gVentolin; analysts see $100 mn sales potential (Soban News)

Cipla has received the US FDA’s approval for generic Ventolin inhaler. Analysts see $100-million sales potential from the drug, which could aid US business outlook​Cipla has received the US FDA’s approval for generic Ventolin inhaler. Analysts see $100-million sales potential from the drug, which could aid US business outlook ​Latest News [ SOBAN NEWS: International and National ]